LUCENTIS INJECTION 1 ML

How LUCENTIS INJECTION 1 ML Works

• LUCENTIS INJECTION 1 ML is a specialized medication classified as a monoclonal antibody. Its primary function is to inhibit angiogenesis, the process by which new blood vessels are formed. In the context of cancer treatment, LUCENTIS INJECTION 1 ML works by specifically targeting and neutralizing a protein called vascular endothelial growth factor (VEGF). VEGF plays a crucial role in stimulating the growth of new blood vessels that supply oxygen and nutrients to cancerous cells.
• By blocking VEGF, LUCENTIS INJECTION 1 ML effectively disrupts the formation of these blood vessels, depriving the cancerous cells of the resources they need to grow and proliferate. This process can significantly slow down the progression of the cancer and limit its ability to spread to other parts of the body. The targeted action of LUCENTIS INJECTION 1 ML minimizes damage to healthy tissues, reducing potential side effects compared to traditional chemotherapy.
• The inhibition of angiogenesis represents a significant advancement in cancer therapy, offering a more precise and effective approach to managing the disease. LUCENTIS INJECTION 1 ML's mechanism of action directly addresses the tumor's dependence on new blood vessel formation for its survival and growth.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

• Conjunctival hemorrhage
• Eye pain
• Increased intraocular pressure
• Foreign body sensation in eyes
• Blurred vision
• Nausea
• Dry eye
• Eye itching
• Cataract
• Vitreous floaters
• Vitreous detachment
• Intraocular inflammation
• Eye irritation
• Increased lacrimation
• Eyelid inflammation
• Ocular hyperemia
• Retinal disorder
• Maculopathy
• Eye discomfort
• Posterior capsule opacification
• Injection site hemorrhage
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Anemia (low number of red blood cells)
• Joint pain
• Renal failure
• Peripheral neuropathy (tingling and numbness of feet and hand)
• Gastro-esophageal reflux disease
• Hypercholesterolemia (high cholesterol)
• Bronchitis (inflammation of the airways)

• Keep LUCENTIS INJ 1ML away from the reach of children and pets.
• Store LUCENTIS INJ 1ML in a refrigerator (2 - 8°C). Do not freeze.

• After receiving LUCENTIS INJECTION 1 ML, you might experience temporary visual disturbances. To ensure your safety and the safety of others, it's crucial to avoid driving or engaging in any activities that demand sharp mental focus until you are confident that LUCENTIS INJECTION 1 ML doesn't impair your vision or cognitive abilities. This precautionary measure will help prevent accidents and ensure you can perform tasks requiring concentration safely.
• It's important to promptly inform your doctor if you notice any concerning changes in your eye health. This includes increased eye pain or redness, blurred or decreased vision, or heightened sensitivity to light. These symptoms could indicate a potential complication, and early reporting will allow your doctor to provide timely evaluation and appropriate treatment. Regular monitoring and communication with your healthcare provider are key to managing your eye health effectively.
• Your eyes may feel more sensitive to light after the injection. Wearing sunglasses, especially when outdoors or in brightly lit environments, can help reduce discomfort and protect your eyes from excessive light exposure. This simple step can make a significant difference in your comfort level during the recovery period.
• If your doctor has prescribed eye drops, be sure to use them as directed. These drops can help lubricate the eye, reduce inflammation, or prevent infection. Following the prescribed dosage and schedule is essential to maximize their effectiveness and promote healing.
• Don't hesitate to ask your doctor if there are any specific activities you should avoid after receiving LUCENTIS INJECTION 1 ML. They can provide personalized recommendations based on your individual condition and treatment plan. Adhering to these guidelines will help minimize the risk of complications and support a smooth recovery.
• Resting your eyes is crucial for recovery. Try to rest your eyes as much as possible for at least a few hours following the injection. This can involve avoiding activities that strain your eyes, such as reading, watching television, or using electronic devices. Giving your eyes a break will allow them to heal and recover more effectively.